Prot# GL02-01: A Randomized, Double-Blind, Multi-Center, Placebo Controlled Study to Assess Prevention of Bone Loss by Treatment with Gl701 (Prestara?) in Women with Systemic Lupus Erythematosus Receiving Treatment with Glucocorticoids

Project: Research project

Project Details

StatusFinished
Effective start/end date1/31/03 → 8/21/10

Funding

  • Genelabs Technologies, Inc. (GL02-01)